(Press-News.org) Resveratrol, an ingredient in red wine thought to improve insulin sensitivity, reduce risk of heart disease and increase longevity, does not appear to offer these benefits in healthy women, new research at Washington University School of Medicine in St. Louis indicates.
The study, reported online Oct. 25 in Cell Metabolism, involved 29 post-menopausal women who did not have type 2 diabetes and who were reasonably healthy. For 12 weeks, half took an over-the-counter resveratrol supplement, and the rest got a placebo, or sugar pill.
"Resveratrol supplements have become popular because studies in cell systems and rodents show that resveratrol can improve metabolic function and prevent or reverse certain health problems like diabetes, heart disease and even cancer," says senior investigator Samuel Klein, MD, director of Washington University's Center for Human Nutrition. "But our data demonstrate that resveratrol supplementation does not have metabolic benefits in relatively healthy, middle-aged women."
The results were somewhat surprising because earlier studies suggested that drinking red wine lowers the risk of health problems.
"Few studies have evaluated the effects of resveratrol in people," Klein explains. "Those studies were conducted in people with diabetes, older adults with impaired glucose tolerance or obese people who had more metabolic problems than the women we studied. So it is possible that resveratrol could have beneficial effects in people who are more metabolically abnormal than the subjects who participated in the study."
Klein, the Danforth Professor of Medicine and Nutritional Science, directs the Division of Geriatrics and Nutritional Science and the Center for Applied Research Sciences. He says many people who have heard about red wine's health benefits want to take resveratrol supplements to get the benefits of red wine without consuming large amounts of alcohol. In recent years, annual U.S. sales of resveratrol supplements have risen to $30 million.
As part of the study, Klein and his colleagues gave 15 post-menopausal women 75 milligrams of resveratrol daily, the same amount they'd get from drinking 8 liters of red wine, and compared their insulin sensitivity to 14 others who took a placebo.
The team measured the women's sensitivity to insulin and the rate of glucose uptake in their muscles, infusing insulin into their bodies and measuring their metabolic response to different doses.
"It's the most sensitive approach we have for evaluating insulin action in people," he says. "And we were unable to detect any effect of resveratrol. In addition, we took small samples of muscle and fat tissue from these women to look for possible effects of resveratrol in the body's cells, and again, we could not find any changes in the signaling pathways involved in metabolism."
But if resveratrol doesn't have a health benefit, then why are red wine drinkers less likely to develop heart disease and diabetes? Klein says there may be something else in red wine that provides the benefit.
"The purpose of our study was not to identify the active ingredient in red wine that improves health but to determine whether supplementation with resveratrol has independent, metabolic effects in relatively healthy people," he says. "We were unable to detect a metabolic benefit of resveratrol supplementation in our study population, but this does not preclude the possibility that resveratrol could have a synergistic effect when combined with other compounds in red wine."
INFORMATION:
Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, Gu C, Kunz I, Fanelli FR, Patterson BW, Klein S. Resveratrol supplementation does not improve metabolic function in non-obese women with normal glucose tolerance. Cell Metabolism vol 16, published on line Oct. 25, 2012
AUDIO:
Ever since researchers discovered that red wine drinkers seemed to have a lower risk for certain health problems, scientists have been trying to learn whether it's possible to get some...
Click here for more information.
Funding for this research comes from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH), and grants from DSM Nutritional Products, the Longer Life Foundation, the Japanese Research Foundation for Clinical Pharmacology, the Manpei Suzuki Diabetes Foundation and the Kanae Foundation for the Promotion of Medical Science. NIH grant numbers UL1 RR024992, DK 56341 and DK 37948.
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Resveratrol falls short in health benefits
2012-10-25
ELSE PRESS RELEASES FROM THIS DATE:
Antibiotics that only partly block protein machinery allow germs to poison themselves
2012-10-25
Powerful antibiotics that scientists and physicians thought stop the growth of harmful bacteria by completely blocking their ability to make proteins actually allow the germs to continue producing certain proteins -- which may help do them in.
The finding, by a team at the University of Illinois at Chicago College of Pharmacy, clarifies how antibiotics work and may aid in the discovery of new drugs or improve clinical therapy with existing ones. The study is published in the Oct. 26 issue of the journal Cell.
Among the most complex molecular machines in the cell are ...
Study reveals rate at which key genetic deletions contribute to male infertility
2012-10-25
CAMBRIDGE, Mass. (October 25, 2012) — A large-scale analysis of Y chromosomes from more than 20,000 men finds that two spontaneously recurring deletions along a complex region of the Y chromosome are responsible for approximately 8% of cases of failed sperm production.
Although previous research had identified deletions in the region of the Y known as AZFc (for azoospermia factor c) as causing severe spermatogenic failure (SSF), this latest analysis, conducted by Whitehead Institute Director David Page and colleagues, is the first to determine how prevalent these deletions ...
The Biggest Loser a big turnoff
2012-10-25
(Edmonton) The Biggest Loser might be a TV ratings winner, but its extreme depiction of exercise is more likely to turn people off than get them off the couch, according to new research from the University of Alberta.
Researchers in the Faculty of Physical Education and Recreation found that watching a short video clip of the Biggest Loser fuelled negative attitudes toward exercise, raising further questions about how physical activity is shown in the popular media.
"The depictions of exercise on shows like The Biggest Loser are really negative," said lead author Tanya ...
Protein regulation linked to intellectual disability
2012-10-25
Genetics researchers at the University of Adelaide have solved a 40-year mystery for a family beset by a rare intellectual disability – and they've discovered something new about the causes of intellectual disability in the process.
While many intellectual disabilities are caused directly by a genetic mutation in the so-called "protein coding" part of our genes, the researchers found that in their case the answer laid outside the gene and in the regulation of proteins.
Protein regulation involves the switching on or off of a protein by specific genes. As a consequence ...
BMJ and Daily Telegraph's fake hip exposes failing European device regulation
2012-10-25
A joint investigation by the BMJ and Daily Telegraph has exposed the major flaws in the current EU system used for regulating medical devices, such as hip replacements and breast implants.
It reveals that some "notified bodies" (the agencies charged with assessing how safe medical devices are before they are sold) are more interested in attracting business than safeguarding patients.
Undercover reports created a fake large diameter metal on metal total hip—called the Changi TMH (Total Metal Hip)—that was based on a device which has been recalled globally for safety ...
Traumatic consequences long after fall of the Berlin Wall
2012-10-25
Previously, there had been a lack of reliable data in Germany on the long-term psychological consequences of political imprisonment in the GDR. Professor Andreas Maercker, Head of the Department of Psychopathology and Clinical Intervention at the University of Zurich, and private lecturer Dr. Matthias Schützwohl, Group Leader at the Clinic and Polyclinic of Psychiatry and Psychotherapy at Dresden University of Technology, interviewed 146 former political prisoners in the mid-1990s. 15 years later, they studied the majority of those concerned (78 men and 15 women) again. ...
Genes, depression and life satisfaction
2012-10-25
Vulnerability to major depression is linked with how satisfied we are with our lives. This association is largely due to genes.
This is the main finding of a new twin study from the Norwegian Institute of Public Health in collaboration with the University of Oslo. The researchers compared longitudinal information from identical and fraternal twins to determine how vulnerability to major depression is associated with dispositional (overall) lifetime satisfaction.
Previous studies have systematically shown that life satisfaction is considerably stable over time. People ...
New opportunity for rapid treatment of malaria
2012-10-25
Researchers have identified a new means to eradicate malaria infections by rapidly killing the blood-borne Plasmodium parasites that cause the disease.
Malaria causes up to 3 million deaths each year, predominantly afflicting vulnerable people such as children under five and pregnant women, in tropical regions of Africa, Asia, and Latin America. Treatments are available for this disease, but the Plasmodium parasite is fast becoming resistant to the most common drugs, and health authorities say they desperately need new strategies to tackle the disease.
This new potential ...
Did the changing climate shrink Europe's ancient hippos?
2012-10-25
Giant German hippopotamuses wallowing on the banks of the Elbe are not a common sight. Yet 1.8 million years ago hippos were a prominent part of European wildlife, when mega-fauna such as woolly mammoths and giant cave bears bestrode the continent. Now palaeontologists writing in Boreas, believe that the changing climate during the Pleistocene Era may have forced Europe's hippos to shrink to pygmy sizes before driving them to warmer climes.
"Species of hippo ranged across pre-historic Europe, including the giant Hippopotamus antiquus a huge animal which often weighed ...
DNA's double stranded stretch
2012-10-25
Theoretical physicists like to play with very unconventional toys. Manoel Manghi from Toulouse University in France and his colleagues have adopted a seemingly playful approach to examining what happens to a double stranded molecule of DNA when it is stretched to the breaking point, in a study about to be published in EPJ E. Instead of using optical tweezers to stretch DNA as previously done in experimental settings, the authors focused on using a theoretical model to account for the structural deformations of DNA and determine how its mechanical characteristics could explain ...